Annual Drug Patent Expirations for ERLEADA Erleada is a drug marketed by Janssen Biotech and is included in one NDA. It is available from one supplier. There are seven patents…
The post New patent for Janssen Biotech drug ERLEADA appeared first on Drug…
Annual Drug Patent Expirations for VIMPAT Vimpat is a drug marketed by Ucb Inc and is included in three NDAs. It is available from three suppliers. There is one patent…
The post New patent for Ucb Inc drug VIMPAT appeared first on DrugPatentWatch – Mak…
Annual Drug Patent Expirations for VIMPAT Vimpat is a drug marketed by Ucb Inc and is included in three NDAs. It is available from three suppliers. There is one patent…
The post New patent for Ucb Inc drug VIMPAT appeared first on DrugPatentWatch – Mak…
Annual Drug Patent Expirations for INVELTYS Inveltys is a drug marketed by Kala Pharms Inc and is included in one NDA. There are eight patents protecting this drug. INVELTYS drug…
The post New patent for Kala Pharms drug INVELTYS appeared first on Drug…
Annual Drug Patent Expirations for EYSUVIS Eysuvis is a drug marketed by Kala Pharms Inc and is included in one NDA. The generic ingredient in EYSUVIS is loteprednol etabonate. Additional…
The post New patent for Kala Pharms drug EYSUVIS appeared first…
Annual Drug Patent Expirations for EPHEDRINE+SULFATE Ephedrine Sulfate is a drug marketed by Akorn, Amneal, Dr Reddys Labs Ltd, Fresenius Kabi Usa, Nevakar, and Sandoz Inc and, and is included…
The post New patent for Nevakar drug EPHEDRINE SULFATE app…
Annual Drug Patent Expirations for HETLIOZ Hetlioz is a drug marketed by Vanda Pharms Inc and is included in one NDA. It is available from one supplier. There are thirteen…
The post New patent for Vanda Pharms drug HETLIOZ appeared first on DrugPatentW…
Annual Drug Patent Expirations for OZEMPIC Ozempic is a drug marketed by Novo and is included in one NDA. It is available from three suppliers. There are twenty-two patents protecting…
The post New patent for NOVO drug OZEMPIC appeared first on DrugPat…
Annual Drug Patent Expirations for GAVRETO Gavreto is a drug marketed by Blueprint Medicines and is included in one NDA. There is one patent protecting this drug. This drug has…
The post New patent for Blueprint Medicines drug GAVRETO appeared first on…
Annual Drug Patent Expirations for INGREZZA Ingrezza is a drug marketed by Neurocrine and is included in one NDA. It is available from one supplier. There are three patents protecting…
The post New patent for Neurocrine drug INGREZZA appeared first on …